Kwalite Pharmaceuticals Limited has scheduled a board meeting for February 12, 2026, at 10:30 AM at its registered office in Amritsar to consider and approve unaudited standalone and consolidated financial results for Q3FY26 ended December 31, 2025. The trading window for designated persons remains closed until 48 hours after results declaration, following the company's December 26, 2025 intimation, ensuring compliance with SEBI regulations.
Kwalite Pharmaceuticals Limited Schedules Board Meeting for February 12, 2026 to Consider Q3FY26 Financial Results
